Capital market investment in the biomedicine field tends to be rational and accurateIn recent years, the biomedicine field has been a popular track in the capital market, but with the intensification of industry competition and the changes in the policy environment, investors have gradually shifted

Zhixiang Jintai GR2303 Injection (anti-TL1A monoclonal antibody) has been approved for clinical trials for inflammatory bowel diseaseRecently, Zhixiang Jintai announced that its independently developed GR2303 injection (anti-TL1A monoclonal antibody) has been approved by the National Drug Administra

The application for the launch of Madenoxavir granules, which is jointly developed by Xiansheng Pharmaceutical and Antikang Bio, has been accepted. It is China's first innovative anti-influenza virus drug for children.Recently, Xiansheng Pharmaceutical and Andikang Biotechnology jointly announced th

The cross-border integration of the biopharmaceutical industry and the development trend of clusters is significantIn recent years, the biopharmaceutical industry has shown a trend of rapid development around the world, especially in cross-border integration and cluster development. Hot topics in th

Large-scale random supervision and random inspections of medical institutions across the country have been launched, focusing on medical expenses, the use of high-value consumables, etc.Recently, the National Health Commission and multiple departments announced the launch of large-scale random super

Kangfang Bio partners update ivonescimab's global phase III clinical HARMONi research data at WCLC2025Recently, Kangfang Bio's partners released the latest data on the global Phase III clinical HARMONi study at the World Lung Cancer Conference (WCLC2025). As an important breakthrough in the field of

Customs tax policy adjustments, tariffs on imported pharmaceutical products such as viral vectors for CAR-T therapy are further reducedRecently, the General Administration of Customs, together with the Ministry of Finance and the State Administration of Taxation, issued a major policy, announcing fu

The process of domestic production of high-end medical devices acceleratesIn recent years, with the rapid development of China's medical and health industry, the localization process of high-end medical devices has accelerated significantly. Driven by policy support, technological innovation and mar

Beijing Tsinghua Chang Gung Hospital displays intelligent drainage treatment device system to improve ICU sensing control and nursingRecently, Beijing Tsinghua Chang Gung Hospital has made a major breakthrough in the field of medical technology innovation and officially demonstrated a set ofIntellig

HPV vaccine will be included in the national immunization programRecently, the National Health Commission released a major news,HPV vaccine will be officially included in the national immunization program, This means that women of appropriate age will have the opportunity to receive HPV vaccine for